Codes / ICD10CM / T50.B14D

T50.B14D Poisoning by smallpox vaccines, undetermined, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by smallpox vaccines, undetermined, subsequent encounter

Summary

This condition involves harmful effects resulting from exposure to smallpox vaccines, with the intent of exposure classified as undetermined. It is categorized as a subsequent encounter, indicating ongoing care related to the poisoning event. Clinical presentation and management depend on the nature of the exposure and the patient's response.

Causes

Exposure to smallpox vaccines may occur through ingestion, injection, or contact with vaccine material. The intent behind the exposure is not clearly established, which may complicate the clinical context. Therapeutic errors or accidental handling could contribute, but the exact cause remains unclear.

Risk Factors

  • Access to smallpox vaccine materials
  • Unclear or undocumented exposure circumstances
  • Prior history of vaccine-related reactions
  • Situations where exposure intent is ambiguous (e.g., unattended vaccine storage)

Symptoms

  • Localized reactions (e.g., swelling, redness at exposure site)
  • Systemic symptoms (e.g., fever, fatigue)
  • Allergic responses (e.g., rash, itching)
  • Gastrointestinal disturbances (e.g., nausea, vomiting)
  • Neurological symptoms (e.g., dizziness, confusion)

Diagnosis

Diagnosis is based on the patient's history of exposure, clinical examination, and symptom evaluation. Laboratory tests or imaging may be used to assess severity or rule out other conditions. The undetermined intent of exposure is documented to guide ongoing care.

Treatment Options

  • Symptomatic relief (e.g., antihistamines for mild reactions, pain management)
  • Monitoring for severe reactions (e.g., anaphylaxis, organ involvement)
  • Supportive care tailored to the patient's clinical status
  • Referral to specialists if complications arise

Prognosis and Follow-Up

Prognosis depends on the severity of the exposure and the patient's response to treatment. Subsequent encounters indicate ongoing management, with follow-up focused on resolving symptoms, preventing complications, and addressing any underlying factors related to the exposure.

Complications

  • Severe allergic reactions (e.g., anaphylaxis)
  • Organ involvement (e.g., cardiac, neurological)
  • Prolonged systemic symptoms
  • Psychological impact from ambiguous exposure intent

Lifestyle & Prevention

  • Ensure proper storage and handling of vaccine materials to minimize accidental exposure.
  • Document exposure circumstances clearly to aid in clinical decision-making.
  • Educate individuals with access to vaccines on safe handling practices.

When to Seek Professional Help

Seek immediate medical attention if severe symptoms (e.g., difficulty breathing, swelling, or confusion) develop. Ongoing care is necessary for subsequent encounters to monitor recovery and address complications.

Tips for Medical Coders

Document the undetermined intent of exposure and subsequent encounter status clearly. Ensure clinical notes support the classification of the poisoning event and any ongoing care provided. Code T50.B14D is specific to undetermined intent and subsequent encounters; verify that documentation aligns with these criteria.

Book a walkthrough

T50.B14D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.